SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

71,909.70 -570.59
( -0.79%)

Global Indices

Nasdaq

51,190.24 242.68
(0.48%)

Dow Jones

7,742.36 54.91
(0.71%)

Hang Seng

68,256.51 -700.21
(-1.02%)

Nikkei 225

10,455.36 27.09
(0.26%)

Forex

USD-INR

96.17 0.25
(0.26%)

EUR-INR

108.49 -0.30
(-0.28%)

GBP-INR

127.16 -0.03
(-0.02%)

JPY-INR

0.61 0.00
(-0.36%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Concord Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543960

INE338H01029

193.0629905

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CONCORDBIO

50.59

14385.25

EPS(TTM)

Face Value()

Div & Yield %

27.18

0.55

Back

sharanam infraproject & trading ltd

Glenmark receives EIR report for formulations facility in Goa

Sep 23,2026

Glenmark Pharmaceuticals announced that it has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (U.S. FDA) for its formulations manufacturing facility in Goa, India with a Voluntary Action Indicated (VAI) status.

The inspection was conducted at the Company's manufacturing facility from 22 June 2026 to 30 June 2026.

71,909.70 -570.59 ( -0.79%)

51,190.24 242.68 (0.48%)

7,742.36 54.91 (0.71%)

68,256.51 -700.21 (-1.02%)

10,455.36 27.09 (0.26%)

96.17 0.25 (0.26%)

108.49 -0.30 (-0.28%)

127.16 -0.03 (-0.02%)

0.61 0.00 (-0.36%)